BOULDER, Colo., Feb. 5, 2015 /PRNewswire/ -- Array BioPharma Inc. ARRY today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Swann Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
|
Event: |
Leerink Swann Healthcare Conference |
|
Presenter: |
Ron Squarer, Chief Executive Officer |
|
Date: |
Wednesday, February 11, 2015 |
|
Time: |
10:15 a.m. Eastern Time |
|
Location: |
The Waldorf Astoria, New York, NY |
|
Webcast: |
|
|
http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-EventDetails&EventId=5184603 | |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently enrolling patients. These programs include two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis). For more information on Array, please go to www.arraybiopharma.com
|
CONTACT: |
Tricia Haugeto |
|
Array BioPharma Inc. | |
|
303-386-1193 | |
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-leerink-swann-global-healthcare-conference-300031621.html
SOURCE Array BioPharma Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
